Seroatlas · Human Serome Atlas

SCG5

Neuroendocrine protein 7B2

Also known as: 7B2, 7B2_HUMAN, SGNE1, SgV

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P05408
Gene
SCG5
Ensembl
ENSG00000166922
Chromosome
15
Canonical length
212 aa
Protein class
Predicted secreted proteins
Secretome location
Secreted to blood

OverviewNCBI Gene

This gene encodes a secreted chaperone protein that prevents the aggregation of other secreted proteins, including proteins that are associated with neurodegenerative and metabolic disease. The encoded protein may be best known for its role in the trafficking and activation of prohormone convertase PC2 (encoded by Gene ID: 5126). Phosphorylation of the encoded protein has been shown to have an inhibitory effect on its chaperone function. This gene also produces a ARHGAP11A-SCG5 readthrough transcript and ARHGAP11A-SCG5 protein. [provided by RefSeq, Feb 2019]

Canonical amino-acid sequenceUniProt

212 residues, UniProt reviewed canonical sequence.

>P05408|SCG5
     1  MVSRMVSTML SGLLFWLASG WTPAFAYSPR TPDRVSEADI QRLLHGVMEQ LGIARPRVEY
    61  PAHQAMNLVG PQSIEGGAHE GLQHLGPFGN IPNIVAELTG DNIPKDFSED QGYPDPPNPC
   121  PVGKTADDGC LENTPDTAEF SREFQLHQHL FDPEHDYPGL GKWNKKLLYE KMKGGERRKR
   181  RSVNPYLQGQ RLDNVVAKKS VPHFSDEDKD PE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SCG5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.54
Highest tissue expression
386 nTPM

Expression across tissuesHPA

Tissue

  • pituitary gland: 386 nTPM
  • choroid plexus: 347 nTPM
  • cerebral cortex: 246 nTPM
  • basal ganglia: 213 nTPM
  • cerebellum: 185 nTPM
  • hypothalamus: 183 nTPM

Single-cell type

  • other brain neurons: 179 nCPM
  • brain inhibitory neurons: 157 nCPM
  • brain excitatory neurons: 125 nCPM
  • oligodendrocytes: 90 nCPM
  • oligodendrocyte progenitor cells: 69 nCPM
  • choroid plexus epithelial cells: 38 nCPM

Immune cell

  • memory CD4 T-cell: 0.3 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM

Brain region

  • hypothalamus: 131 nTPM
  • cerebral cortex: 130 nTPM
  • choroid plexus: 128 nTPM
  • basal ganglia: 83 nTPM
  • hippocampal formation: 77 nTPM
  • spinal cord: 77 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about SCG5.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 65 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Disease | ImmuneIEDB

Conditions an epitope on SCG5 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.22
gnomAD pLI
0
gnomAD missense Z
0.61
DepMap mean gene effect
-0.35
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

  • Neuroendocrine 7B2 precursor
  • Neuroendocrine protein 7B2 precursor (Secretogranin V)

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SCG5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SCG5 as an antibody target. Whether an autoantibody or antibody against SCG5 could matter depends on whether native SCG5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SCG5 is annotated as secreted, so native SCG5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label SCG5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SCG5. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...